Avalon GloboCare Corp. (GENEXOSOME TECHNOLOGIES INC.)

Company Snapshot

Founded: 2016
Entity Type: Public
Employees: 2
Region: U.S.
Revenue: $1.4 Millions
Revenue Year: 2025
Headquarter: U.S.
Key Geographics: North America
Corporate Address: 4400 Route 9 South Suite 3100 Freehold, New Jersey 07728 U.S. Tel. +1-(732)-780-4400 www.avalon-globocare.com

Company Overview

GenExosome Technologies Inc., a subsidiary of Avalon GloboCare, is developing exosome-based diagnostics and therapeutic products under the Exosome Isolation System platform.

GenExosome’s pipeline of projects include early detection of oral cancer (saliva), ovarian cancer (plasma) and kidney cancer (urine); skin regeneration and antifibrosis; and treatment of degenerative disorders.

GenExosome markets GET-Exosome Isolation Kits and exosome isolation, sorting and fluorescence labeling services.

In October 2018, GenExosome partnered with Weill Cornell Medicine to standardize processing of cGMP-level exosomes for clinical studies. Weill Cornell will use the GenExosome Exosome Isolation platform. The partners will standardize cGMP-grade exosome isolation from human endothelial cells and identify and isolate tissue-specific exosome for liquid biopsy applications.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Avalon GloboCare Corp. (GENEXOSOME TECHNOLOGIES INC.) In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

BCC Market Research Report for global liquid biopsy research tools, liquid biopsy biomarkers, technologies, services and diagnostics markets.

Next Generation Cancer Diagnostics: Technologies and Global Markets

global market and technologies for next generation cancer diagnostics. Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025. ...

Company's Business Segments

  • Real Property Operations Expenses : This segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to the company's rental properties.

Applications/End User Industries

  • Biotechnology
  • Healthcare
  • Pharmaceutical
  • Life Sciences
AI Sentiment